Overview

Leuprolide acetate is a synthetic GnRH agonist that, when administered continuously, downregulates pituitary GnRH receptors and suppresses luteinizing hormone (LH) secretion. In ferrets with adrenocortical disease, this reduces the LH-driven sex steroid output from the abnormal adrenal cortex and controls clinical signs such as alopecia, vulvar swelling, and prostatic enlargement.

Leuprolide was the first-line medical therapy for ferret adrenal disease for many years and remains a reasonable and effective option, though the deslorelin implant has largely replaced it in practices where the implant is available. The main drawback of leuprolide is the need for repeat injections on a monthly or 3-4 month schedule, compared with a single implant lasting 1-2 years.

Uses

  • Medical management of adrenocortical disease in ferrets, including:
    • Symmetric alopecia
    • Vulvar swelling in spayed females
    • Prostatic enlargement in neutered males
    • Pruritus
    • Behavioral changes, aggression

Dosage

Dosing is based on clinical experience and has varied over the years:

  • 1-month depot: approximately 100-250 mcg per ferret IM or SC, repeated every 28-30 days
  • 4-month depot: approximately 2 mg per ferret IM or SC, repeated every 3-4 months
  • Doses should be tailored to the individual ferret’s body weight and clinical response

Because the depot formulation must be reconstituted carefully and divided into small doses, it is typically compounded or aliquoted at the clinic. The small body size of ferrets (0.7-2 kg) means injection volumes are very small and demand careful preparation.

Side Effects

Leuprolide is generally well tolerated. Reported effects include:

  • Mild transient discomfort at the injection site
  • Initial “flare” phase where signs may briefly worsen in the first 1-2 weeks
  • Rare failure to respond
  • Occasional injection-site inflammation or sterile abscess
  • Hot flashes and lethargy have been reported rarely

Drug Interactions

  • Commonly combined with prednisolone for concurrent insulinoma — no adverse interaction
  • May reduce endogenous cortisol modestly, which can exacerbate hypoglycemia in ferrets with insulinoma — monitor blood glucose
  • No significant interactions with routine antibiotics, NSAIDs, or gastroprotectants

Contraindications

  • Known hypersensitivity to GnRH analogs
  • Intact breeding ferrets (suppresses fertility)
  • Use caution in ferrets with severe concurrent insulinoma — monitor glucose closely after initiation

FAQs

Leuprolide or deslorelin — which is better? Both work by the same mechanism. Deslorelin implants are preferred in most modern practices because a single implant controls signs for 12-24 months, while leuprolide requires repeat injections. Leuprolide remains useful when deslorelin implants are unavailable, or for owners who prefer injections.

How soon will I see improvement? Hair regrowth typically begins within 4-8 weeks. Vulvar swelling and behavioral changes often improve within 2-4 weeks.

Does leuprolide treat the tumor? No. Like deslorelin, it suppresses the hormonal output but does not shrink or cure the adrenal mass.

How often are repeat injections needed? Monthly for the 1-month depot, or every 3-4 months for the longer-acting formulation. Your veterinarian will pick the schedule that best fits your ferret.

Is it safe with insulinoma? Yes, with monitoring. Many ferrets receive leuprolide and prednisolone simultaneously for the combined adrenal/insulinoma presentation.